These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1781976)

  • 1. Efficacy and clinical relevance of cognition enhancers.
    Herrmann WM; Stephan K
    Alzheimer Dis Assoc Disord; 1991; 5 Suppl 1():S7-12. PubMed ID: 1781976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
    Sinforiani E; Iannuccelli M; Mauri M; Costa A; Merlo P; Bono G; Nappi G
    Int J Clin Pharmacol Res; 1990; 10(1-2):69-74. PubMed ID: 2387665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam.
    Herrmann WM; Stephan K
    Int Psychogeriatr; 1992; 4(1):25-44. PubMed ID: 1391670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piracetam for dementia or cognitive impairment.
    Flicker L; Grimley Evans J
    Cochrane Database Syst Rev; 2000; (2):CD001011. PubMed ID: 10796585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piracetam for dementia or cognitive impairment.
    Flicker L; Grimley Evans G
    Cochrane Database Syst Rev; 2001; (2):CD001011. PubMed ID: 11405971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing practice with cognition enhancers in outpatient care: are there differences regarding type of dementia?--Results of a representative survey in lower Saxony, Germany.
    Stoppe G; Sandholzer H; Staedt J; Winter S; Kiefer J; Rüther E
    Pharmacopsychiatry; 1996 Jul; 29(4):150-5. PubMed ID: 8858714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
    Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study).
    Caramelli P; Laks J; Palmini AL; Nitrini R; Chaves ML; Forlenza OV; Vale Fde A; Barbosa MT; Bottino CM; Machado JC; Charchat-Fichman H; Lawson FL
    Arq Neuropsiquiatr; 2014 Jun; 72(6):411-7. PubMed ID: 24964105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
    Cipolli C; Chiari G
    Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nimodipine in the treatment of old age dementias.
    Ban TA; Morey L; Aguglia E; Azzarelli O; Balsano F; Marigliano V; Caglieris N; Sterlicchio M; Capurso A; Tomasi NA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):525-51. PubMed ID: 2236581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree.
    Villardita C; Grioli S; Lomeo C; Cattaneo C; Parini J
    Neuropsychobiology; 1992; 25(1):24-8. PubMed ID: 1603291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methodology of a clinical controlled study of L-acetylcarnitine].
    Neri M; Cortelloni C; De Vreese L
    Clin Ter; 1990 Mar; 132(6 Suppl):457-68. PubMed ID: 2140970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Piracetam, nimodipine and tacrine in the pharmacologic treatment of dementia: bibliographic review].
    Ojer Tsakiridu D; Dosantos Hernández JO; Larrabe Medina J; Sánchez Casado JI; Sologuren Echenagusia A
    Aten Primaria; 1996 Sep; 18(5):257-60, 262-4. PubMed ID: 8936720
    [No Abstract]   [Full Text] [Related]  

  • 17. Current clinical trials of cognitive enhancers in Japan.
    Shimizu M
    Alzheimer Dis Assoc Disord; 1991; 5 Suppl 1():S13-24. PubMed ID: 1781970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-acetylcarnitine treatment of mental decline in the elderly.
    Salvioli G; Neri M
    Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of piracetam in cognitive impairment: a meta-analysis.
    Waegemans T; Wilsher CR; Danniau A; Ferris SH; Kurz A; Winblad B
    Dement Geriatr Cogn Disord; 2002; 13(4):217-24. PubMed ID: 12006732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.